OB Hemorrhage Toolkit V3.0 (2022)

Key Changes in the revised toolkit include:

• Expanded guidance on obstetric hemorrhage risk factor assessment to include parameters for continued re-evaluation of risk and an updated Obstetric Hemorrhage Risk Screen Table

• Increased emphasis on the importance of assessment for concealed hemorrhage 

• Updated medication protocols and recommendations on the use of tranexamic acid (TXA) as an adjunctive therapy

• Multiple new chapters, including:

  • Management of Iron Deficiency Anemia

  • Secondary Obstetric Hemorrhage and Readmission

  • Implementing and Sustaining Maternal Quality, Safety and Performance Improvement for Obstetric Hemorrhage

The toolkit is available to download after logging into CMQCC's website. If you do not already have a CMQCC Account, you will need to complete a brief survey to initialize an account.

Download:

Improving Health Care Response to Obstetric Hemorrhage Toolkit, Version 3.0 (2022)

Errata: Table Chart Appendix C and Flow Chart Appendix D erroneously depicted that methylergonovine is given in Stage 1 as a standard practice. The intention is to perform the interventions listed in Stage 1, but not hesitate to MOVE ON to a 2nd level uterotonic if there is no response to Stage 1 measures. Methylergonovine would be the preferred choice if the patient is not hypertensive due to the lower cost and relative lack of side effects, however, carboprost is acceptable for patients that do not have a history of asthma. Misoprostol should be reserved for patients that have contraindications to the other two medications. Both appendices have been edited to reflect this workflow.

Informational Webinar Recording and Webinar Slideset 

Individual sections of the toolkit are also available to download by clicking on the links below:

• Appendix A: Classification of Evidence Grading
• Appendix B: Obstetric Hemorrhage Care Guidelines: Checklist Format 
• Appendix C: Obstetric Hemorrhage Care Guidelines: Table Format
• Appendix D: Obstetric Hemorrhage Care Guidelines: Flowchart Format
• Appendix E: Checklist: Carts, Kits and Trays 
• Appendix F: Simulations and Drills: Guidelines for Simulation Scenario Development 
• Appendix G: Simulations and Drills Sample Scenarios 
• Appendix H: Checklist for Patients Who May Decline the Use of Blood Products 
• Appendix I: Discharge Planning for Women with Hemorrhage During the Birth Hospital Stay 
• Appendix J: Sample Obstetric Outpatient Intravenous Iron Infusion
• Appendix K: Obstetric Hemorrhage Risk Factor Assessment Screen
• Appendix L: Hemorrhage ED Visit Stop Sign
• Appendix L: Hemorrhage ED Visit Stop Sign, Spanish Language 
• Appendix M: Sample QBL Worksheet 
• Appendix N: Techniques for Quantitative Assessment of Blood Loss (QBL) 
• Appendix O: Terms and Techniques for Describing Blood Loss 
• Appendix P: Sample Paper Calculators for Quantifying Blood Loss 
• Appendix Q: Sample Schematic: Preadmission Planning for Women Undergoing Scheduled Cesarean Section 
• Appendix R: Medications for Postpartum Hemorrhage 
• Appendix S: Sample Massive Transfusion Policy – Torrance 
• Appendix T: Sample Massive Transfusion Procedure Miller Children’s and Women’s Hospital 
• Appendix U: Sample Code Crimson Postpartum Hemorrhage Management 
• Appendix V: A Guide to Recognizing Acute Stress Disorder in Postpartum Women in the Hospital Setting 
• Appendix W: Patient and Family Support Checklist for Postpartum Hemorrhage 
• Appendix X: Life After Postpartum Hemorrhage 
• Appendix Y: Resources for Postpartum Hemorrhage Survivors 
• Appendix Z: Sample Patient Summary Form: Obstetric Hemorrhage Event 
• Appendix AA: Sample Script: Provider - Patient Postpartum Hemorrhage Post-Event Discussion 
• Appendix BB: FAQ What do patients need to know? 
• Appendix CC: Sample Hemorrhage Rapid Debrief Form 
• Appendix DD: Sample Labor and Delivery Event Debrief Form 
• Appendix EE: Alert on Blood Transfusion Procedure Coding 
• Appendix FF: Obstetric Hemorrhage Sample Order Set Staged